fashion -WSS

fashion

author：comprehensive 2025-09-30 17:05:25 - browse：2662

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Despite FDA concern, risk that CAR

focus

WSS

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Organ aging and disease risk measured by new blood test

What to do when lifesaving products contribute to climate change

Organ aging and disease risk measured by new blood test

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

What don’t we know about an Alzheimer’s drug side effect?

knowledge

fashion

focus

Activists slam private health insurers over coverage restrictions

An outrageous hospital charge: I paid $710 for an hour of babysitting

Drug repurposing or repositioning? The language matters

CDC: Cases of alpha

Affirmative action in medical school literally saved lives

ReNAgade cuts staff seven months after raising $300 million

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ford recalls 870K F

Drug repurposing or repositioning? The language matters

What to do when lifesaving products contribute to climate change

focus

VC firm RA Capital starts a new synthetic biology incubator

With clinical trial data readouts, here's how to spot spin

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Despite FDA concern, risk that CAR

Ending health disparities requires full federal government, panel says

BIO selects John Crowley as new CEO

focus

focus

focus

explore